Crinetics Pharmaceuticals Inc Working Capital to Net Assets Ratio
Crinetics Pharmaceuticals Inc working capital to net assets ratio. Crinetics Pharmaceuticals Inc (CRNX) has a Working Capital to Net Assets ratio of 97.7% as of June 2026. Working capital of $1.16 Billion (current assets of $1.24 Billion minus current liabilities of $79.92 Million) is measured against net assets of $1.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Crinetics Pharmaceuticals Inc (2016–2025)
Working capital to net assets ratio of Crinetics Pharmaceuticals Inc from 2016 to 2025. This chart shows how Crinetics Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of June 2026, the ratio stands at 97.7%, reflecting working capital of $1.16 Billion against net assets of $1.19 Billion USD. Explore Crinetics Pharmaceuticals Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.
Crinetics Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2016–2025)
Crinetics Pharmaceuticals Inc working capital to net assets ratio by year from 2016 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Crinetics Pharmaceuticals Inc from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Crinetics Pharmaceuticals Inc (CRNX) total assets.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 97.1% | $963.27 Million | $992.08 Million | $1.05 Billion | $85.07 Million | ▼ -2.2 pp |
| 2024 | 99.3% | $1.32 Billion | $1.32 Billion | $1.38 Billion | $59.68 Million | ▲ +1.0 pp |
| 2023 | 98.4% | $530.21 Million | $539.11 Million | $574.15 Million | $43.94 Million | ▼ -2.0 pp |
| 2022 | 100.4% | $317.46 Million | $316.33 Million | $345.18 Million | $27.72 Million | ▲ +1.3 pp |
| 2021 | 99.0% | $328.73 Million | $331.94 Million | $344.72 Million | $15.99 Million | ▲ +0.2 pp |
| 2020 | 98.9% | $167.00 Million | $168.92 Million | $177.49 Million | $10.49 Million | ▲ +0.7 pp |
| 2019 | 98.2% | $115.00 Million | $117.14 Million | $123.34 Million | $8.34 Million | ▼ -0.9 pp |
| 2018 | 99.1% | $158.76 Million | $160.22 Million | $166.68 Million | $7.92 Million | ▲ +194.1 pp |
| 2017 | -95.0% | $14.27 Million | $-15.02 Million | $15.16 Million | $897.00K | ▲ +90.0 pp |
| 2016 | -185.0% | $11.47 Million | $-6.20 Million | $12.37 Million | $890.00K | — |